🚀 Demo Launch 2025

Bringing the hospital to home, via space

Enabling the shift from intravenous (IV) to subcutaneous (SC) injection by harnessing the benefits of microgravity for large-scale crystallization of protein drugs

Enabling the shift from intravenous (IV) to subcutaneous (SC) injection by harnessing the benefits of microgravity for large-scale crystallization of protein drugs

Video credit : NASA

Video credit : NASA

Backed By

Credit: Axiom Space

Credit: Axiom Space

Who are We?

We are aiming to be the go-to pharmaceuticals factory in microgravity, part of the space manufacturing revolution, currently developing a platform for large-scale crystallization of protein drugs

Why Now?

There is an increasing demand for home based care due to the ever-increasing demands on hospitals, resulting in a push to develop drugs that can be self-administered at home.

Crystallization of protein drugs enables this switch from IV to SC administration.

There is an increasing demand for home based care due to the ever-increasing demands on hospitals, resulting in a push to develop drugs that can be self-administered at home.

Crystallization of protein drugs enables this switch from IV to SC administration.

Video Credit: NASA

On Earth

On Earth

Video Credit: NASA

In Space

In Space

Video Credit: NASA

On Earth

Why Space?

Why Space?

Why Space?

Crystallization of antibodies is tough! On Earth, sedimentation and convection currents hinder the crystallization process.

Crystallization in a microgravity environment has been shown to result in more perfect crystals with a smaller size distribution. These are far better for pharmaceutical use.

What Are We Doing?
Want to Get Involved?

What Are We Doing?
Want to Get Involved?

Here at BioOrbit we are developing hardware to efficiently crystallize protein drugs both on a small and large scale. We want to work with pharmaceutical companies and researchers who are interested in how crystallization in microgravity will affect the end product.

Contact us for more info, questions or just a hello!

The Team

CEO

CEO

Dr. Katie King

Dr. Katie King

CSO

CSO

Dr. Leonor Teles

Dr. Leonor Teles

Engineering

Engineering

Thomas Ganzeboom

Thomas Ganzeboom

Biotech Science

Biotech Science

Clément Roumegoux

Clément Roumegoux

Business

Business

Dídac Cabús

Dídac Cabús

© 2023 BioOrbit, LTD

© 2023 BioOrbit, LTD

© 2023 BioOrbit, LTD